{"id":"https://openalex.org/W2887865014","doi":"https://doi.org/10.1158/1538-7445.am2018-310","title":"Abstract 310: AZD4573, a novel CDK9 inhibitor, rapidly induces cell death in hematological tumor models through depletion of Mcl1","display_name":"Abstract 310: AZD4573, a novel CDK9 inhibitor, rapidly induces cell death in hematological tumor models through depletion of Mcl1","alternate_titles":[],"publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887865014","doi":"https://doi.org/10.1158/1538-7445.am2018-310","mag":"2887865014"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-310","doi":"https://doi.org/10.1158/1538-7445.am2018-310","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-310","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2887865014"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043764611","display_name":"Justin R. Cidado","orcid":"https://orcid.org/0000-0003-1748-4438","observed_orcids":["https://orcid.org/0000-0003-1748-4438"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Justin Cidado","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007120197","display_name":"Theresa A. Proia","orcid":"https://orcid.org/0009-0000-4572-5118","observed_orcids":["https://orcid.org/0009-0000-4572-5118"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theresa Proia","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035216859","display_name":"Scott Boiko","orcid":"https://orcid.org/0009-0000-8596-6944","observed_orcids":["https://orcid.org/0009-0000-8596-6944"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott Boiko","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041949186","display_name":"Maryann San Martin","orcid":"https://orcid.org/0009-0006-9371-410X","observed_orcids":["https://orcid.org/0009-0006-9371-410X"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maryann San Martin","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002091193","display_name":"Steven W. Criscione","orcid":"https://orcid.org/0000-0002-6550-5769","observed_orcids":["https://orcid.org/0000-0002-6550-5769"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven Criscione","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024275380","display_name":"Douglas Ferguson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Douglas Ferguson","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000020580","display_name":"Wenlin Shao","orcid":"https://orcid.org/0000-0003-2417-2221","observed_orcids":["https://orcid.org/0000-0003-2417-2221","https://orcid.org/0000-0003-0894-8210"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wenlin Shao","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090795154","display_name":"Lisa Drew","orcid":"https://orcid.org/0000-0002-5912-8338","observed_orcids":["https://orcid.org/0000-0002-5912-8338"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa Drew","raw_affiliation_strings":["AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210150756"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"310","last_page":"310"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.07810000330209732,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azd4573","display_name":"AZD4573","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cdk9-inhibitor","display_name":"CDK9 inhibitor","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7609999775886536},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9150000214576721},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.5920000076293945},{"id":"https://openalex.org/keywords/bak","display_name":"Bak","score":0.5720000267028809},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.9980000257492065},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/rna-polymerase-ii-ser2-phosphorylation","display_name":"RNA polymerase II Ser2 phosphorylation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/azd5991","display_name":"AZD5991","score":0.8849999904632568},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.7350000143051147},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C2779176958","wikidata":"https://www.wikidata.org/wiki/Q18028939","display_name":"MCL1","level":4,"score":0.8601866364479065},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.5865915417671204},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5606029629707336},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5128743648529053},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4939435124397278},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4784519672393799},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.436884343624115},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4326721727848053},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4119434654712677},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.40021586418151855},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.3258037269115448},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2626720666885376},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14802676439285278},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.0},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-310","doi":"https://doi.org/10.1158/1538-7445.am2018-310","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-310","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2987340690","https://openalex.org/W2886305883","https://openalex.org/W2506353115","https://openalex.org/W2912491356","https://openalex.org/W2889975947","https://openalex.org/W4244369116","https://openalex.org/W3111631565","https://openalex.org/W3214410062","https://openalex.org/W2739797138","https://openalex.org/W2885143194"],"abstract_inverted_index":{"Cyclin-dependent":[0],"kinase":[1],"9":[2],"(CDK9)":[3],"regulates":[4],"elongation":[5],"of":[6,10,115,158,195,202,223,236,257,279,304,315,322,337,343,444,449],"transcription":[7],"through":[8,251,442],"phosphorylation":[9],"RNA":[11],"polymerase":[12],"II":[13],"(pSer2-RNAPII),":[14],"and":[15,24,31,39,46,51,97,104,120,170,193,272,296,307,313,328,364],"its":[16],"short-term":[17],"inhibition":[18,157,247],"downregulates":[19],"genes":[20,71,84],"with":[21,36,62,107,145,160,210,234,301,370,394,404],"short-lived":[22],"transcripts":[23],"labile":[25],"proteins.":[26],"We":[27],"developed":[28],"a":[29,130,164,199,231,293,401,430],"novel":[30,431],"selective":[32],"CDK9":[33,77,159,246,432],"inhibitor,":[34,239,433],"AZD4573,":[35,161,344,429],"nanomolar":[37],"potency":[38],"physicochemical":[40],"properties":[41],"suitable":[42],"for":[43,64,392,453],"IV":[44],"administration":[45],"short":[47],"exposure.":[48],"Initial":[49],"transcriptomic":[50],"proteomic":[52],"analyses":[53],"were":[54,72],"performed":[55],"on":[56,86,213,375],"MCF7":[57],"breast":[58],"cancer":[59,178],"cells":[60,267],"treated":[61],"AZD4573":[63,108,183,224,290,356,378,405],"4h":[65],"or":[66,389],"8h":[67],"to":[68,133,143,166,187,292,333,361],"determine":[69],"which":[70],"most":[73,95],"rapidly":[74,434],"modulated":[75],"by":[76],"inhibition.":[78],"Of":[79],"the":[80,92,102,116,134,185,226,237,266,276,280,285,323,359,450],"1,290":[81],"genetically-linked,":[82],"cancer-associated":[83],"analyzed":[85],"these":[87],"platforms,":[88],"MCL1":[89,110],"ranked":[90],"amongst":[91],"top":[93],"as":[94,386],"robustly":[96],"sustainably":[98],"suppressed":[99],"at":[100],"both":[101],"mRNA":[103,306],"protein":[105,320],"level":[106],"treatment.":[109],"is":[111,121],"an":[112,252,381],"anti-apoptotic":[113,325],"member":[114],"BCL2":[117],"gene":[118],"family":[119],"frequently":[122],"amplified":[123],"and/or":[124,259],"over-expressed":[125],"in":[126,152,173,225,261,299,310,345,350,368,390,406,438],"various":[127],"cancers,":[128],"conferring":[129],"survival":[131],"advantage":[132],"tumor":[135,353,440],"cell.":[136],"Mcl1":[137,169,238,305,445],"has":[138],"also":[139,357],"been":[140],"notoriously":[141],"difficult":[142],"drug":[144],"small":[146],"molecules,":[147],"although":[148],"inhibitors":[149],"are":[150],"now":[151],"early":[153],"clinical":[154],"development.":[155],"Transient":[156],"however,":[162],"provides":[163],"means":[165],"indirectly":[167],"target":[168],"induce":[171,188],"apoptosis":[172,282],"Mcl1-addicted":[174],"tumors.":[175],"In":[176,284,318],"human":[177],"cell":[179,227,249,263,273,287,316,436],"line":[180,228],"panel":[181],"screens,":[182],"demonstrated":[184],"ability":[186,360],"rapid":[189,294],"caspase":[190,206,270,311],"activation":[191],"(6h)":[192],"loss":[194,303,314],"viability":[196],"(24h)":[197],"across":[198],"diverse":[200],"set":[201],"hematological":[203,352,395,439],"cancers":[204],"(median":[205,216],"EC50=30nM,":[207],"GI50=11nM)":[208],"but":[209],"minimal":[211],"effect":[212],"solid":[214],"tumors":[215],"EC50":[217],"&":[218],"GI50":[219],">30\u03bcM).":[220],"The":[221],"activity":[222],"panels":[229],"displayed":[230],"strong":[232],"correlation":[233],"that":[235],"AZD5991":[240],"(r2":[241],"=":[242],"0.837),":[243],"suggesting":[244],"transient":[245],"induces":[248,435],"death":[250,437],"Mcl1-dependent":[253],"mechanism.":[254],"Furthermore,":[255],"knockdown":[256],"BAK":[258],"BAX":[260],"sensitive":[262],"lines":[264],"rescued":[265],"from":[268],"AZD4573-mediated":[269],"induction":[271,312],"death,":[274],"underscoring":[275],"mechanistic":[277],"involvement":[278],"intrinsic":[281],"pathway.":[283],"AML":[286],"line,":[288],"MV411,":[289],"led":[291],"dose-":[295],"time-dependent":[297],"decrease":[298],"pSer2-RNAPII":[300],"concomitant":[302],"protein,":[308],"resulting":[309],"viability.":[317],"contrast,":[319],"levels":[321],"other":[324],"proteins,":[326],"Bcl2":[327],"BclxL,":[329],"remained":[330],"unchanged":[331],"out":[332],"6h":[334],"post-AZD4573":[335],"treatment":[336,383],"MV411":[338],"cells.":[339],"With":[340],"intermittent":[341],"dosing":[342],"vivo":[346],"efficacy":[347],"was":[348],"observed":[349],"multiple":[351,371],"xenograft":[354],"models.":[355],"exhibited":[358],"drive":[362],"deeper":[363],"more":[365],"durable":[366],"regressions":[367],"combination":[369],"targeted":[372],"agents.":[373],"Based":[374],"our":[376],"findings,":[377],"could":[379],"be":[380],"effective":[382],"option,":[384],"either":[385],"single":[387],"agent":[388],"combination,":[391],"patients":[393],"malignancies.":[396],"Thus,":[397],"we":[398],"have":[399],"initiated":[400],"first-time-in-human":[402],"study":[403],"October":[407],"2017":[408],"(NCT03263637).":[409],"Citation":[410],"Format:":[411],"Justin":[412],"Cidado,":[413],"Theresa":[414],"Proia,":[415],"Scott":[416],"Boiko,":[417],"Maryann":[418],"San":[419],"Martin,":[420],"Steven":[421],"Criscione,":[422],"Douglas":[423],"Ferguson,":[424],"Wenlin":[425],"Shao,":[426],"Lisa":[427],"Drew.":[428],"models":[441],"depletion":[443],"[abstract].":[446],"In:":[447],"Proceedings":[448],"American":[451],"Association":[452],"Cancer":[454,467],"Research":[455],"Annual":[456],"Meeting":[457],"2018;":[458],"2018":[459],"Apr":[460],"14-18;":[461],"Chicago,":[462],"IL.":[463],"Philadelphia":[464],"(PA):":[465],"AACR;":[466],"Res":[468],"2018;78(13":[469],"Suppl):Abstract":[470],"nr":[471],"310.":[472]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2887865014","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-08-22T00:00:00"}
